| 1. |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. The Lancet, 2022, 399(10342): 2227-2242.
|
| 2. |
Aliberti S, Goeminne PC, O’Donnell AE, et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med 2022;10(3): 298-306.
|
| 3. |
Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. European Respiratory Journal, 2015, 45(2): 310-313.
|
| 4. |
Du Q, Jin J, Liu X, Sun Y. Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta‐analysis. PLoS One 2016, 11(3): e0150532.
|
| 5. |
Kim Y, Kim K, Rhee CK, et al. Increased hospitalizations and economic burden in COPD with bronchiectasis: a nationwide representative study. Scientific Reports, 2022, 12(1): 3829.
|
| 6. |
Agustí A, Celli BR, Criner GJ, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 2023, 207(7): 819-837.
|
| 7. |
Mao B, Lu HW, Li MH, et al. The existence of bronchiectasis predicts worse prognosis in patients with COPD. Scientific Reports, 2015, 5(1): 10961.
|
| 8. |
Barker AF. Bronchiectasis. N Engl J Med, 2002, 346(18): 1383-1393.
|
| 9. |
Lu HY, Liao KM. The incidence of bronchiectasis in chronic obstructive pulmonary disease. Open Medicine, 2022, 17(1): 1927-1934.
|
| 10. |
Jin J, Yu W, Li S, et al. Factors associated with bronchiectasis in patients with moderate–severe chronic obstructive pulmonary disease. Medicine, 2016, 95(29): e4219.
|
| 11. |
Traversi L, Miravitlles M, Martinez-Garcia MA, et al. ROSE: radiology, obstruction, symptoms and exposure – a delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC airways working group. ERJ Open Research, 2021, 7(4): 399-2021.
|
| 12. |
Ni Y, Shi G, Yu Y, et al. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease, 2015, 10(1): 1465-1475.
|
| 13. |
Tan WC, Hague CJ, Leipsic J, et al. Findings on thoracic computed tomography scans and respiratory outcomes in persons with and without chronic obstructive pulmonary disease: A population-based cohort study. PLoS One, 2016, 11(11): e0166745.
|
| 14. |
薛强, 陈俊文, 李平. 慢性阻塞性肺病合并支气管扩张症发生机制. 临床肺科杂志, 2022, 27(8): 1248-1251.
|
| 15. |
Qi Y, Yan Y, Tang D, et al. Inflammatory and immune mechanisms in COPD: current status and therapeutic prospects. Journal of Inflammation Research, 2024, 17: 6603-6618.
|
| 16. |
Perea L, Faner R, Chalmers JD, et al. Pathophysiology and genomics of bronchiectasis. European Respiratory Review, 2024, 33(173): 240055.
|
| 17. |
Van Eeden SF, Hogg JC. Immune-modulation in chronic obstructive pulmonary disease: current concepts and future strategies. Respiration, 2020, 99(7): 550-565.
|
| 18. |
Martinez‐Garcia MA, Sibila O, Aliberti S. Bronchiectasis: A pulmonary disease with systemic consequences. Respirology, 2022, 27(11): 923-925.
|
| 19. |
King PT, Morgan L. Bronchiectasis in adults: aetiology and new therapies. Journal of Clinical Medicine, 2022, 11(19): 5957.
|
| 20. |
Kayongo A, Robertson NM, Siddharthan T, et al. Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease. Frontiers in Immunology, 2023, 13: 1085551.
|
| 21. |
Narayana JK, Tsaneva-Atanasova K, Chotirmall SH. Microbiomics-focused data integration: a fresh solve for the rubik’s cube of endophenotyping? American Journal of Respiratory and Critical Care Medicine, 2022, 206(4): 365-368.
|
| 22. |
Chen YF, Hou HH, Chien N, et al. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study. Respiratory Research, 2024, 25(1): 308.
|
| 23. |
Huang JTJ, Cant E, Keir HR, et al. Endotyping chronic obstructive pulmonary disease, bronchiectasis, and the “chronic obstructive pulmonary disease-bronchiectasis association”. American Journal of Respiratory and Critical Care Medicine, 2022, 206(4): 417-426.
|
| 24. |
Dai Z, Zhong Y, Cui Y, et al. Analysis of clinical characteristics, prognosis and influencing factors in patients with bronchiectasis-chronic obstructive pulmonary disease overlap syndrome: a prospective study for more than five years. Journal of global health, 2024, 14: 04129.
|
| 25. |
Tiew PY, Jaggi TK, Chan LLY, et al. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap. Clinical Respiratory Journal, 2021, 15(2): 123-133.
|
| 26. |
LaFon DC, Dransfield MT. Bronchiectasis-chronic obstructive pulmonary disease overlap: A ROSE by any other name? American Journal of Respiratory and Critical Care Medicine, 2024, 210(1): 20-21.
|
| 27. |
Sahin H, Naz I, Susam S, et al. The effect of the presence and severity of bronchiectasis on the respiratory functions, exercise capacity, dyspnea perception, and quality of life in patients with chronic obstructive pulmonary disease. Annals of Thoracic Medicine, 2020, 15(1): 26-32.
|
| 28. |
Kim SH, Kim C, Jeong I, et al. Chronic obstructive pulmonary disease is associated with decreased quality of life in bronchiectasis patients: findings from the KMBARC registry. Frontiers in Medicine, 2021, 8: 722124.
|
| 29. |
齐玉晶, 宾雁飞, 何志义. 慢性阻塞性肺疾病合并支气管扩张的相关临床研究. 中国呼吸与危重监护杂志, 2019, 18(05): 484-487.
|
| 30. |
叶梓楠, 杨婕, 胡建武, 等. 慢性阻塞性肺疾病合并支气管扩张患者的临床特征和高危因素分析. 临床肺科杂志, 2024, 29(09): 1330-1335.
|
| 31. |
Zhang X, Pang L, Lv X, et al. Risk factors for bronchiectasis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Clinics (Sao Paulo, Brazil), 2021, 76: e2420.
|
| 32. |
Chung WS, Lin CL. Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: a population-based cohort study. Respiratory Medicine, 2018, 140: 6-10.
|
| 33. |
Kim Y, Han K, Yoo J, et al. Risk factors of incident lung cancer in patients with non-cystic fibrosis bronchiectasis: a korean population-based study. Cancers, 2022, 14(11): 2604.
|
| 34. |
Mariniello DF, D’Agnano V, Cennamo D, et al. Comorbidities in COPD: current and future treatment challenges. Journal of Clinical Medicine, 2024, 13(3): 743.
|
| 35. |
Balkissoon R. Journal club - bronchiectasis/COPD overlap: syndrome versus treatable trait? Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 2019, 6(2): 193-199.
|
| 36. |
Gramegna A, Barone I, Alicandro G, et al. The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis. ERJ Open Research, 2024, 10(5): 1032-2023.
|
| 37. |
Polverino E, Dimakou K, Hurst J, et al. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. European Respiratory Journal, 2018, 52(3): 1800328.
|
| 38. |
Polverino E, De Soyza A, Dimakou K, et al. The association between bronchiectasis and chronic obstructive pulmonary disease: data from the european bronchiectasis registry (EMBARC). American Journal of Respiratory and Critical Care Medicine, 2024, 210(1): 119-127.
|
| 39. |
Dhar R, Singh S, Talwar D, et al. Clinical outcomes of bronchiectasis in India: data from the EMBARC/respiratory research network of india registry. European Respiratory Journal, 2023, 61(1): 2200611.
|
| 40. |
Maselli DJ, Yen A, Wang W, et al. Small airway disease and emphysema are associated with future exacerbations in smokers with CT-derived bronchiectasis and COPD: results from the COPDGene cohort. Radiology, 2021, 300(3): 706-714.
|
| 41. |
De La Rosa-Carrillo D, De Granda-Orive JI, Diab Cáceres L, et al. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine, 2024, 18(5): 255-268.
|
| 42. |
Saleem F, Hur SA, Cahalan M, et al. International guideline recommendations and eligibility criteria for home oxygen therapy. The Lancet. Respiratory Medicine, 2023, 11(5): 402-405.
|
| 43. |
Jacobs SS, Krishnan JA, Lederer DJ, et al. Home oxygen therapy for adults with chronic lung disease. An official American thoracic society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 2020, 202(10): e121-e141.
|
| 44. |
张波, 曾红美, 李星茹, 等. 家庭经鼻高流量氧疗在慢性阻塞性肺疾病中的应用研究进展. 中国呼吸与危重监护杂志, 2024, 23(12): 894-899.
|
| 45. |
Jácome C, Jácome M, Correia S, et al. Effectiveness, adherence and safety of home high flow nasal cannula in chronic respiratory disease and respiratory insufficiency: a systematic review. Archivos De Bronconeumologia, 2024, 60(8): 490-502.
|
| 46. |
Xiong T, Bai X, Wei X, et al. Exercise rehabilitation and chronic respiratory diseases: effects, mechanisms, and therapeutic benefits. International Journal of Chronic Obstructive Pulmonary Disease, 2023, 18: 1251-1266.
|
| 47. |
刘思敏, 王谦鑫宏, 刘俊楠, 等. 全身振动训练在重度慢性阻塞性肺疾病中的康复机制研究进展. 中国呼吸与危重监护杂志, 2023, 22(4): 289-294.
|
| 48. |
Araújo AS, Figueiredo MR, Lomonaco I, et al. Effects of pulmonary rehabilitation on systemic inflammation and exercise capacity in bronchiectasis: a randomized controlled trial. Lung, 2022, 200(3): 409-417.
|
| 49. |
Şahin ME, Satar S, Ergün P. Long-term efficiency of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease, bronchiectasis, and asthma: does it differ? Turkish Journal of Medical Sciences, 2023, 53(3): 814-823.
|
| 50. |
Chalmers JD, Shoemark A. Inhaled corticosteroids in COPD and bronchiectasis. Chest, 2023, 164(4): 809-811.
|
| 51. |
Martínez-García MÁ, Oscullo G, García-Ortega A, et al. Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: from bench to bedside. A narrative review. Drugs, 2022, 82(14): 1453-1468.
|
| 52. |
Ritchie AI, Singayagam A, Mitchell S, et al. The effect of inhaled corticosteroids on pneumonia risk in patients with COPD-bronchiectasis overlap: a UK population-based case-control study. Chest, 2023, 164(4): 875-884.
|
| 53. |
Martinez-Garcia MA, Miravitlles M. The impact of chronic bronchial infection in COPD: a proposal for management. International Journal of Chronic Obstructive Pulmonary Disease, 2022, 17: 621-630.
|
| 54. |
吴俊, 张玲, 顾东伟, 等. 单纯性支气管扩张症与支气管扩张症-慢性阻塞性肺疾病重叠综合征患者的病原菌对比研究. 中国全科医学, 2025, 28(06): 729-736.
|
| 55. |
Yang J, Xu JF, Liang S. Antibiotic resistance in pseudomonas aeruginosa: mechanisms and emerging treatment. Critical Reviews in Microbiology, 2024: 1-19.
|
| 56. |
Qin S, Xiao W, Zhou C, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduction and Targeted Therapy, 2022, 7(1): 199.
|
| 57. |
Ding L, Wang J, Cai S, et al. Pulmonary biofilm-based chronic infections and inhaled treatment strategies. International Journal of Pharmaceutics, 2021, 604: 120768.
|
| 58. |
Guan WJ, Xu JF, Luo H, et al. A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with pseudomonas aeruginosa infection. Chest, 2023, 163(1): 64-76.
|
| 59. |
Choi Y, Shin SH, Lee H, et al. Favorable response to long-term azithromycin therapy in bronchiectasis patients with chronic airflow obstruction compared to chronic obstructive pulmonary disease patients without bronchiectasis. International journal of chronic obstructive pulmonary disease, 2021, 16: 855-863.
|
| 60. |
Hocquigny A, Hugerot H, Ghanem R, et al. Mucoactive drugs and multiple applications in pulmonary disease therapy. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e. V, 2024, 194: 110-117.
|
| 61. |
Shen Y, Huang S, Kang J, et al. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). International Journal of Chronic Obstructive Pulmonary Disease, 2018, 13: 399-407.
|
